- Este evento ha pasado.
Convocatoria de Expresiones de Interés COVID-19 del Clúster Salud de Horizonte Europa
13 abril 2021 | 8:00 am - 6 mayo 2021 | 5:00 pm
La Comisión Europea acaba de publicar un Programa de Trabajo extraordinario sobre COVID19 del Clúster 1 (Salud) dentro del nuevo Programa Marco Horizonte Europa https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-4-health_horizon-2021-2022_en.pdf.
Esta convocatoria extraordinaria se enmarca en el nuevo Plan europeo de preparación en materia de biodefensa frente a las variantes de COVID-19, llamado «HERA Incubator».
La convocatoria de expresiones de interés abrirá el 13 de abril y cerrará el 6 de Mayo.
En dicha convocatoria se incluirán 2 topics:
- HORIZON-HLTH-2021-CORONA-01-01 – Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment (https://bit.ly/3motKXh).
El topic está dotado con un presupuesto de 30 millones de euros. La horquilla de financiación recomendada por la EC para las propuestas está entre 3 y 10 M€.
La Comisión espera financiar al menos una propuesta de vacunas y al menos una propuesta de terapias.
- HORIZON-HLTH-2021-CORONA-01-02 – Cohorts united against COVID-19 variants of concern (https://bit.ly/3uuL13P).
El topic está dotado con un presupuesto de millones de euros. La horquilla de financiación recomendada por la EC para las propuestas está entre 7 y 10 M€
Condiciones especiales de la convocatoria:
- Elegibilidad países: In particular, due to the urgency of this action and geographical relevance of this action and considering the Union’s interest to retain, in principle, relations with the countries associated to Horizon 2020, and other third countries in the process of association to Horizon Europe, legal entities established in Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo*, Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine and United Kingdom are eligible for funding from the Union even if the Horizon Europe association agreement with the third country concerned does not apply at the time of signature of the grant agreement.
- Evaluación: In order to ensure a balanced portfolio covering responses to different aspects of the public health emergency under the specific actions above, and within each specific action, grants will be awarded to applications not only in order of ranking, but also to those projects that enhance the quality of the project portfolio through synergies between projects and avoidance of overlaps, provided that the applications attain all thresholds.
- Disposiciones de emergencia pública: beneficiaries must comply with the public emergency related provisions listed in the General Annexes of the Work Programme 2021 (part G – Legal and financial set-up of the grant agreements) and in the Model Grant Agreement concerning the project implementation under Intellectual Property Rights (IPR), background and results, access rights and rights of use (article 16 and Annex 5) for the duration of the pandemic; and under Communication, dissemination, open science and visibility (article 17 and Annex 5) during the entire duration of the action and for four years after the end of the action.
- Formulario para estudios en humanos: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/essential-information-for-clinical-studies_horizon_en.pdf